Heartflow vs Cleerly: A Real IP Filing With Competitive Stakes - But No Ticker Here
The Opportunity
The upstream signal is framed as negative legal risk, and 7A resolves it as SHORT, but the underlying story is more interesting: an IP lawsuit can be a competitive weapon, especially if injunctive relief is plausible. The reason this is AVOID is mechanical: no tradeable instrument is provided in this workflow for Heartflow, so you cannot take the view in-market here.
The Timing
Freshness is 50 due to missing hydration, but the artefact trail looks stronger than most single-source legal signals: a company PR and a docketing surface exist. What would convert this into a tradeable situation is a mapped public instrument (ticker) and an early procedural milestone: a filed complaint you can read, a motion for injunction, or a credible countersuit that changes expected outcomes.
The Evidence
7.2 surfaced a GlobeNewswire press release stating Heartflow filed a patent infringement lawsuit against Cleerly in the Eastern District of Texas and describing asserted patents and remedies; a Law360 docket index also appears to corroborate existence (even if details are paywalled). Links: globenewswire.com and law360.com .